{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T21:09:28Z","timestamp":1774472968939,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Military Institute of Medicine, Poland","award":["415"],"award-info":[{"award-number":["415"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sarcoidosis is a multisystemic granulomatous disease with still unknown etiology. Our previous studies showed a significantly higher percentage of CD34\u2009+\u2009cells in the peripheral blood in patients with sarcoidosis (SA) compared to the control group. The objective of the present study was to characterized of the CD34\u2009+\u2009cell population in peripheral blood in patients with SA with reference to the control group. Moreover in patients with SA, fibrocytes and endothelial cells were analysed and their relationship to the fibrosis process based on assessment of diffusing capacity for carbon monoxide (DLCO).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data from patients diagnosed with SA at Military Institute of Medicine (Warsaw, Poland) between January 2018 and December 2019 were collected and analysed ongoing basis. Peripheral blood was collected from 26 patients with newly diagnosed pulmonary SA and 16 healthy subjects. The immunomagnetic method and flow cytometry were used. Among the CD34+ progenitor cells were assessed: low-differentiated cells, hematopoietic progenitor cells and endothelial progenitor cells. The Statistica 12.0 software was used for a statistical analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We observed a significantly higher percentage of low-differentiated cells (13.8 vs. 2.3, <jats:italic>P<\/jats:italic>\u2009=\u20090.001) and endothelial cells (0.3 vs. 0.0, <jats:italic>P<\/jats:italic>\u2009=\u20090.001) in patients with SA compared to the control group. In the study group the median proportion of fibrocytes was 1.877% (0.983\u20132.340) in patients with DLCO&lt;\u200980%, while in patients with DLCO&gt;\u200980% was 0.795% (0.139\u20131.951) (<jats:italic>P<\/jats:italic>\u2009=\u20090.72). The median proportion of endothelial progenitor cells was higher in patients with DLCO&lt;\u200980%: 0.889% (0.391\u20131.741), than in patients with DLCO&gt;\u200980%: 0.451% (0.177\u20130.857) (<jats:italic>P<\/jats:italic>\u2009=\u20090.44).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In conclusion we demonstrated for the first time the immunophenotype of peripheral CD34\u2009+\u2009cells with the degree of their differentiation. The study confirmed the involvement of low differentiated cells and endothelial cells in patients with SA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-020-01345-x","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T05:34:59Z","timestamp":1605850499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Role of fibrocytes and endothelial progenitor cells among low-differentiated CD34+ cells in the progression of lung sarcoidosis"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9727-2576","authenticated-orcid":false,"given":"Rutkowska","family":"El\u017cbieta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwiecie\u0144","family":"Iwona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bednarek","family":"Joanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jahnz-R\u00f3\u017cyk","family":"Karina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rzepecki","family":"Piotr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,20]]},"reference":[{"issue":"21","key":"1345_CR1","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1056\/NEJMra071714","volume":"357","author":"MC Iannuzzi","year":"2007","unstructured":"Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357(21):2153\u201365.","journal-title":"N Engl J Med"},{"issue":"5","key":"1345_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1164\/rccm.201006-0865CI","volume":"183","author":"RP Baughman","year":"2011","unstructured":"Baughman RP, Culver DA, Judson MA. A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med. 2011;183(5):573\u201381.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"1345_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ccm.2008.03.014","volume":"29","author":"AK Gerke","year":"2008","unstructured":"Gerke AK, Hunninghake G. The immunology of sarcoidosis. Clin Chest Med. 2008;29(3):379\u201390 vii.","journal-title":"Clin Chest Med"},{"issue":"2","key":"1345_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/resp.12199","volume":"19","author":"M Tercelj","year":"2014","unstructured":"Tercelj M, Salobir B, Zupancic M, Wraber B, Rylander R. Inflammatory markers and pulmonary granuloma infiltration in sarcoidosis. Respirology. 2014;19(2):225\u201330.","journal-title":"Respirology"},{"issue":"9363","key":"1345_CR5","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/S0140-6736(03)12888-7","volume":"361","author":"RP Baughman","year":"2003","unstructured":"Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet. 2003;361(9363):1111\u20138.","journal-title":"Lancet"},{"issue":"2","key":"1345_CR6","first-page":"149","volume":"16","author":"GW Hunninghake","year":"1999","unstructured":"Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, Eklund A, Kitaichi M, Lynch J, Rizzato G, Rose C, Selroos O, Semenzato G, Sharma OP. ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16(2):149\u201373.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"3","key":"1345_CR7","first-page":"182","volume":"31","author":"I Mochizuki","year":"2014","unstructured":"Mochizuki I, Kubo K, Hond T. Widespread heavy damage of capillary endothelial cells in the pathogenesis of sarcoidosis--evidence by monoclonal von Willebrand factor immunohistochemistry in the bronchus and lung of patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31(3):182\u201390.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"227","key":"1345_CR8","first-page":"250","volume":"38","author":"T Plusa","year":"2015","unstructured":"Plusa T, Chelstowska S. CD34+ progenitor cells in pulmonary sarcoidosis. Polski Merkur Lekarski. 2015;38(227):250\u20133.","journal-title":"Polski Merkur Lekarski"},{"issue":"4","key":"1345_CR9","first-page":"367","volume":"80","author":"CC Stella","year":"1995","unstructured":"Stella CC, Cazzola M, De Fabritiis P, De Vincentiis A, Gianni AM, Lanza F, Lauria F, Lemoli RM, Tarella C, Zanon P, et al. CD34-positive cells: biology and clinical relevance. Haematologica. 1995;80(4):367\u201387.","journal-title":"Haematologica"},{"issue":"1","key":"1345_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1590\/S1516-31802009000100004","volume":"127","author":"JM Carvalho","year":"2009","unstructured":"Carvalho JM, Souza MK, Buccheri V, Rubens CV, Kerbauy J, Oliveira JS. CD34-positive cells and their subpopulations characterized by flow cytometry analyses on the bone marrow of healthy allogenic donors. Sao Paulo Med J. 2009;127(1):12\u20138.","journal-title":"Sao Paulo Med J"},{"issue":"1","key":"1345_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2174\/1573398052953613","volume":"1","author":"BB Moore","year":"2005","unstructured":"Moore BB, Thannickal VJ, Toews GB. Bone marrow-derived cells in the pathogenesis of lung fibrosis. Curr Respir Med Rev. 2005;1(1):69\u201376.","journal-title":"Curr Respir Med Rev"},{"issue":"8","key":"1345_CR12","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1164\/rccm.201303-0479OC","volume":"188","author":"T Nakashima","year":"2013","unstructured":"Nakashima T, Liu T, Yu H, Ding L, Ullenbruch M, Hu B, Wu Z, Oguro H, Phan SH. Lung bone marrow-derived hematopoietic progenitor cells enhance pulmonary fibrosis. Am J Respir Crit Care Med. 2013;188(8):976\u201384.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"1345_CR13","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.bbadis.2013.01.022","volume":"1832","author":"A Mackinnon","year":"2013","unstructured":"Mackinnon A, Forbes S. Bone marrow contributions to fibrosis. Biochim Biophys Acta. 2013;1832(7):955\u201361.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"1345_CR14","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1513\/AnnalsATS.201303-069FR","volume":"10","author":"KC Patterson","year":"2013","unstructured":"Patterson KC, Strek ME. Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes. Ann Am Thorac Soc. 2013;10(4):362\u201370.","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"1345_CR15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/MCP.0000000000000301","volume":"22","author":"CA Bonham","year":"2016","unstructured":"Bonham CA, Strek ME, Patterson KC. From granuloma to fibrosis: sarcoidosis associated pulmonary fibrosis. Curr Opin Pulm Med. 2016;22(5):484\u201391.","journal-title":"Curr Opin Pulm Med"},{"issue":"130","key":"1345_CR16","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1183\/09059180.00007713","volume":"22","author":"S Maharaj","year":"2013","unstructured":"Maharaj S, Shimbori C, Kolb M. Fibrocytes in pulmonary fibrosis: a brief synopsis. Eur Respir Rev. 2013;22(130):552\u20137.","journal-title":"Eur Respir Rev"},{"issue":"1","key":"1345_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12931-018-0798-8","volume":"19","author":"P Heukels","year":"2018","unstructured":"Heukels P, van Hulst JAC, van Nimwegen M, Boorsma CE, Melgert BN, van den Toorn LM, Boomars KAT, Wijsenbeek MS, Hoogsteden H, von der Thusen JH, Hendriks RW, Kool M, van den Blink B. Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis. Respir Res. 2018;19(1):90.","journal-title":"Respir Res"},{"issue":"2","key":"1345_CR18","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1183\/09031936.00112809","volume":"35","author":"GP Fadini","year":"2010","unstructured":"Fadini GP, Avogaro A, Ferraccioli G, Agostini C. Endothelial progenitors in pulmonary hypertension: new pathophysiology and therapeutic implications. Eur Respir J. 2010;35(2):418\u201325.","journal-title":"Eur Respir J"},{"issue":"4","key":"1345_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10456-011-9228-y","volume":"14","author":"HT Duong","year":"2011","unstructured":"Duong HT, Erzurum SC, Asosingh K. Pro-angiogenic hematopoietic progenitor cells and endothelial colony-forming cells in pathological angiogenesis of bronchial and pulmonary circulation. Angiogenesis. 2011;14(4):411\u201322.","journal-title":"Angiogenesis"},{"issue":"2","key":"1345_CR20","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1183\/09031936.00034810","volume":"37","author":"A Huertas","year":"2011","unstructured":"Huertas A, Palange P. Circulating endothelial progenitor cells and chronic pulmonary diseases. Eur Respir J. 2011;37(2):426\u201331.","journal-title":"Eur Respir J"},{"issue":"7","key":"1345_CR21","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1634\/stemcells.2005-0440","volume":"24","author":"GP Fadini","year":"2006","unstructured":"Fadini GP, Schiavon M, Cantini M, Baesso I, Facco M, Miorin M, Tassinato M, de Kreutzenberg SV, Avogaro A, Agostini C. Circulating progenitor cells are reduced in patients with severe lung disease. Stem Cells. 2006;24(7):1806\u201313.","journal-title":"Stem Cells"},{"issue":"3","key":"1345_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1183\/09031936.06.00120604","volume":"27","author":"P Palange","year":"2006","unstructured":"Palange P, Testa U, Huertas A, Calabro L, Antonucci R, Petrucci E, Pelosi E, Pasquini L, Satta A, Morici G, Vignola MA, Bonsignore MR. Circulating haemopoietic and endothelial progenitor cells are decreased in COPD. Eur Respir J. 2006;27(3):529\u201341.","journal-title":"Eur Respir J"},{"issue":"7","key":"1345_CR23","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1164\/ajrccm.176.7.724a","volume":"176","author":"GP Fadini","year":"2007","unstructured":"Fadini GP, Schiavon M, Rea F, Avogaro A, Agostini C. Depletion of endothelial progenitor cells may link pulmonary fibrosis and pulmonary hypertension. Am J Respir Crit Care Med. 2007;176(7):724\u20135 author reply 725.","journal-title":"Am J Respir Crit Care Med"},{"key":"1345_CR24","doi-asserted-by":"crossref","unstructured":"Graham BL, Brusasco V, Burgos F, Cooper BG, Jensen R, Kendrick A, MacIntyre NR, Thompson BR, Wanger J. 2017 ERS\/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J. 2017;49(1):1600016.","DOI":"10.1183\/13993003.00016-2016"},{"issue":"2","key":"1345_CR25","first-page":"84","volume":"80","author":"H Ranu","year":"2011","unstructured":"Ranu H, Wilde M, Madden B. Pulmonary function tests. Ulster Med J. 2011;80(2):84\u201390.","journal-title":"Ulster Med J"},{"key":"1345_CR26","doi-asserted-by":"publisher","first-page":"236905","DOI":"10.1155\/2014\/236905","volume":"2014","author":"AD Birnbaum","year":"2014","unstructured":"Birnbaum AD, Rifkin LM. Sarcoidosis: sex-dependent variations in presentation and management. J Ophthalmol. 2014;2014:236905.","journal-title":"J Ophthalmol"},{"issue":"2","key":"1345_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2478\/v10039-008-0014-z","volume":"53","author":"E Danila","year":"2008","unstructured":"Danila E, Jurgauskiene L, Malickaite R. BAL fluid cells and pulmonary function in different radiographic stages of newly diagnosed sarcoidosis. Adv Med Sci. 2008;53(2):228\u201333.","journal-title":"Adv Med Sci"},{"issue":"5","key":"1345_CR28","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1378\/chest.08-2569","volume":"136","author":"VS Polychronopoulos","year":"2009","unstructured":"Polychronopoulos VS, Prakash UBS. Airway involvement in sarcoidosis. Chest. 2009;136(5):1371\u201380.","journal-title":"Chest"},{"key":"1345_CR29","doi-asserted-by":"crossref","unstructured":"Johnson DC. DLCO: adjust for lung volume, standardised reporting and interpretation. Eur Respir J. 2017;50(2):1701144.","DOI":"10.1183\/13993003.00940-2017"},{"issue":"6","key":"1345_CR30","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1378\/chest.125.6.2061","volume":"125","author":"C Lamberto","year":"2004","unstructured":"Lamberto C, Nunes H, Le Toumelin P, Duperron F, Valeyre D, Clerici C. Membrane and capillary blood components of diffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis: relation to exercise gas exchange. Chest. 2004;125(6):2061\u20138.","journal-title":"Chest"},{"issue":"Suppl 1","key":"1345_CR31","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1186\/1755-1536-5-S1-S22","volume":"5","author":"B Mehrad","year":"2012","unstructured":"Mehrad B, Strieter RM. Fibrocytes and the pathogenesis of diffuse parenchymal lung disease. Fibrogenesis Tissue Repair. 2012;5(Suppl 1):S22.","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"3","key":"1345_CR32","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1172\/JCI200420997","volume":"114","author":"RJ Phillips","year":"2004","unstructured":"Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, Belperio JA, Keane MP, Strieter RM. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest. 2004;114(3):438\u201346.","journal-title":"J Clin Invest"},{"issue":"5","key":"1345_CR33","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1189\/jlb.0309132","volume":"86","author":"RM Strieter","year":"2009","unstructured":"Strieter RM, Keeley EC, Hughes MA, Burdick MD, Mehrad B. The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis. J Leukoc Biol. 2009;86(5):1111\u20138.","journal-title":"J Leukoc Biol"},{"issue":"7","key":"1345_CR34","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1164\/rccm.200810-1534OC","volume":"179","author":"A Moeller","year":"2009","unstructured":"Moeller A, Gilpin SE, Ask K, Cox G, Cook D, Gauldie J, Margetts PJ, Farkas L, Dobranowski J, Boylan C, O'Byrne PM, Strieter RM, Kolb M. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2009;179(7):588\u201394.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"1345_CR35","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1161\/CIRCULATIONAHA.108.808246","volume":"119","author":"DM Smadja","year":"2009","unstructured":"Smadja DM, Gaussem P, Mauge L, Israel-Biet D, Dignat-George F, Peyrard S, Agnoletti G, Vouhe PR, Bonnet D, Levy M. Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease. Circulation. 2009;119(3):374\u201381.","journal-title":"Circulation"},{"issue":"6","key":"1345_CR36","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1183\/09031936.00130809","volume":"36","author":"DM Smadja","year":"2010","unstructured":"Smadja DM, Mauge L, Sanchez O, Silvestre JS, Guerin C, Godier A, Henno P, Gaussem P, Israel-Biet D. Distinct patterns of circulating endothelial cells in pulmonary hypertension. Eur Respir J. 2010;36(6):1284\u201393.","journal-title":"Eur Respir J"},{"issue":"1","key":"1345_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.atherosclerosis.2005.12.024","volume":"188","author":"AD Blann","year":"2006","unstructured":"Blann AD, Pretorius A. Circulating endothelial cells and endothelial progenitor cells: two sides of the same coin, or two different coins? Atherosclerosis. 2006;188(1):12\u20138.","journal-title":"Atherosclerosis"},{"issue":"10","key":"1345_CR38","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1161\/01.CIR.0000136813.89036.21","volume":"110","author":"M Valgimigli","year":"2004","unstructured":"Valgimigli M, Rigolin GM, Fucili A, Porta MD, Soukhomovskaia O, Malagutti P, Bugli AM, Bragotti LZ, Francolini G, Mauro E, Castoldi G, Ferrari R. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation. 2004;110(10):1209\u201312.","journal-title":"Circulation"},{"issue":"1","key":"1345_CR39","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/01.STR.0000149944.15406.16","volume":"36","author":"U Ghani","year":"2005","unstructured":"Ghani U, Shuaib A, Salam A, Nasir A, Shuaib U, Jeerakathil T, Sher F, O'Rourke F, Nasser AM, Schwindt B, Todd K. Endothelial progenitor cells during cerebrovascular disease. Stroke. 2005;36(1):151\u20133.","journal-title":"Stroke"},{"issue":"1","key":"1345_CR40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2337\/diabetes.53.1.195","volume":"53","author":"CJ Loomans","year":"2004","unstructured":"Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B, Rabelink TJ, van Zonneveld AJ. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes. 2004;53(1):195\u20139.","journal-title":"Diabetes"},{"issue":"22","key":"1345_CR41","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1161\/01.CIR.0000039526.42991.93","volume":"106","author":"OM Tepper","year":"2002","unstructured":"Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002;106(22):2781\u20136.","journal-title":"Circulation"},{"issue":"2","key":"1345_CR42","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1161\/01.CIR.0000151875.21836.AE","volume":"111","author":"J Grisar","year":"2005","unstructured":"Grisar J, Aletaha D, Steiner CW, Kapral T, Steiner S, Seidinger D, Weigel G, Schwarzinger I, Wolozcszuk W, Steiner G, Smolen JS. Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation. 2005;111(2):204\u201311.","journal-title":"Circulation"},{"issue":"7","key":"1345_CR43","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1161\/01.ATV.0000133488.56221.4a","volume":"24","author":"JH Choi","year":"2004","unstructured":"Choi JH, Kim KL, Huh W, Kim B, Byun J, Suh W, Sung J, Jeon ES, Oh HY, Kim DK. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol. 2004;24(7):1246\u201352.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"23","key":"1345_CR44","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1161\/hc2301.092122","volume":"103","author":"S Shintani","year":"2001","unstructured":"Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, Sasaki K, Shimada T, Oike Y, Imaizumi T. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation. 2001;103(23):2776\u20139.","journal-title":"Circulation"},{"issue":"12","key":"1345_CR45","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1093\/eurheartj\/ehi164","volume":"26","author":"AM Leone","year":"2005","unstructured":"Leone AM, Rutella S, Bonanno G, Abbate A, Rebuzzi AG, Giovannini S, Lombardi M, Galiuto L, Liuzzo G, Andreotti F, Lanza GA, Contemi AM, Leone G, Crea F. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J. 2005;26(12):1196\u2013204.","journal-title":"Eur Heart J"},{"issue":"12","key":"1345_CR46","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.ehj.2004.03.026","volume":"25","author":"J George","year":"2004","unstructured":"George J, Goldstein E, Abashidze S, Deutsch V, Shmilovich H, Finkelstein A, Herz I, Miller H, Keren G. Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur Heart J. 2004;25(12):1003\u20138.","journal-title":"Eur Heart J"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-020-01345-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12890-020-01345-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-020-01345-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T05:35:07Z","timestamp":1605850507000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-020-01345-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,20]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1345"],"URL":"https:\/\/doi.org\/10.1186\/s12890-020-01345-x","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,20]]},"assertion":[{"value":"23 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We confirm that written informed consent was obtained from all participants of our study \u2013 Military Institute of Medicine of Medicine Ethics Committee n. 37\/WIM\/2015.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"306"}}